ANYO Labs is proud to announce our participation in the Marie Skłodowska-Curie Actions (MSCA) staff exchange project called "Chiron".
The MSCA is a prestigious research and innovation program funded by the European Union, aimed at supporting researchers' career development and fostering international collaborations. Specifically, the MSCA-SE (Staff Exchange) program promotes knowledge sharing and collaboration between academia and industry.
We strongly believe in the power of research and collaboration to drive innovation in the biotech industry. Being part of the Chiron project allows us to collaborate closely with leading academic institutions and talented researchers, exchanging expertise and ideas to advance our cutting-edge technologies.
As a research-driven company, we value the importance of staying at the forefront of scientific advancements. The Chiron project provides us with a unique opportunity to deepen our connections with the research community and tap into a vast network of experts in various fields.
Through this collaboration, we aim to leverage the knowledge and insights gained from the Chiron project to further enhance our AI-driven drug discovery platform. By combining our expertise in artificial intelligence and molecular modelling, we strive to accelerate the development of innovative therapies and contribute to advancements in the field of biopharmaceuticals